Novartis Pharma AG

  • Novartis class 1 new drug Sinimod approved in China

    On May 11, the State Food and Drug Administration issued an announcement to approve the listing of the first class of innovative drug Sinimod tablets (trade name: Wan Li Neng) declared by Novartis Pharma AG through the priority review and approval process for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease.